4
Changes in Ownership
IMMUCELL CORP /DE/ Filed Acc 0001437749-26-037085
President and CEO acquired 16,393 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| te Boekhorst Paul Francis Olivier President and CEO | 2026-11-12 | Option exercise | +16,393 | $6.10 | $99,997 | 34,131 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| te Boekhorst Paul Francis Olivier President and CEO | 2026-11-12 | Option exercise · Incentive Stock Options (Right to buy) | −16,393 | 57,884 | D: show line 2 in the form |
Loading xslF345X06/rdgdoc.xml…